Revvity (RVTY) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $154.71, +1.70% vs the prior close of $152.12.
- Volume 2.37M shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RVTY rises 1.7% to $154.71. Closed at $154.71, +1.70% vs the prior close of $152.12. Day range $148.83–$156.86, opened at $151.91.
RVTY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — RVTY rises 1.7% to $154.71
- Closed at $154.71, +1.70% vs the prior close of $152.12. Day range $148.83–$156.86, opened at $151.91.
- Volume was 2.37M shares, 1.3x its 50-day average of 1.86M.
- Price is +14.3% vs its 50-day average ($135.36) and +42.1% vs its 200-day average ($108.84).
- 52-week range $81.22–$166.25; today's close sits at 86% of that range, 6.9% below the 52-week high.
Oct 14, 2026 — RVTY dips 1.9% to $152.12
- Closed at $152.12, -1.91% vs the prior close of $155.08. Day range $151.45–$158.00, opened at $154.26.
- Volume was 2.02M shares, 1.1x its 50-day average of 1.87M.
- Price is +13.0% vs its 50-day average ($134.56) and +40.1% vs its 200-day average ($108.55).
- 52-week range $81.22–$166.25; today's close sits at 83% of that range, 8.5% below the 52-week high.
Oct 13, 2026 — RVTY dips 0.3% to $155.08
- Closed at $155.08, -0.34% vs the prior close of $155.61. Day range $153.10–$157.46, opened at $156.44.
- Volume was 1.39M shares, 0.7x its 50-day average of 1.89M.
- Price is +15.9% vs its 50-day average ($133.75) and +43.2% vs its 200-day average ($108.27).
- 52-week range $81.22–$166.25; today's close sits at 87% of that range, 6.7% below the 52-week high.
Oct 12, 2026 — RVTY rises 0.9% to $155.61
- Closed at $155.61, +0.93% vs the prior close of $154.18. Day range $153.46–$156.33, opened at $153.74.
- Volume was 1.12M shares, 0.6x its 50-day average of 1.89M — lighter than usual.
- Price is +17.0% vs its 50-day average ($132.95) and +44.1% vs its 200-day average ($107.98).
- 52-week range $81.22–$166.25; today's close sits at 87% of that range, 6.4% below the 52-week high.
Oct 9, 2026 — RVTY rises 1.3% to $154.18
- Closed at $154.18, +1.33% vs the prior close of $152.16. Day range $152.40–$155.50, opened at $152.40.
- Volume was 1.22M shares, 0.6x its 50-day average of 1.91M.
- Price is +16.7% vs its 50-day average ($132.09) and +43.2% vs its 200-day average ($107.69).
- 52-week range $81.22–$166.25; today's close sits at 86% of that range, 7.3% below the 52-week high.
Oct 8, 2026 — RVTY dips 0.9% to $152.16
- Closed at $152.16, -0.94% vs the prior close of $153.60. Day range $146.70–$152.54, opened at $152.04.
- Volume was 1.46M shares, 0.8x its 50-day average of 1.93M.
- Price is +15.9% vs its 50-day average ($131.28) and +41.7% vs its 200-day average ($107.41).
- 52-week range $81.22–$166.25; today's close sits at 83% of that range, 8.5% below the 52-week high.
Oct 7, 2026 — RVTY ends flat (+0.2%) to $153.60
- Closed at $153.60, +0.20% vs the prior close of $153.30. Day range $149.25–$156.01, opened at $153.03.
- Volume was 2.23M shares, 1.2x its 50-day average of 1.92M.
- Price is +17.7% vs its 50-day average ($130.50) and +43.4% vs its 200-day average ($107.13).
- 52-week range $81.22–$166.25; today's close sits at 85% of that range, 7.6% below the 52-week high.
Oct 6, 2026 — RVTY dips 2.6% to $153.30
- Closed at $153.30, -2.58% vs the prior close of $157.36. Day range $151.45–$166.25, opened at $161.62.
- Volume was 2.68M shares, 1.4x its 50-day average of 1.89M.
- Price is +18.2% vs its 50-day average ($129.66) and +43.5% vs its 200-day average ($106.84).
- 52-week range $81.22–$166.25; today's close sits at 85% of that range, 7.8% below the 52-week high.
Oct 5, 2026 — RVTY jumps 3.8% to $157.36, a 52-week high
- Closed at $157.36, +3.85% vs the prior close of $151.53. Day range $150.39–$157.45, opened at $151.45.
- Volume was 1.55M shares, 0.8x its 50-day average of 1.88M.
- Price is +22.2% vs its 50-day average ($128.75) and +47.7% vs its 200-day average ($106.56).
- 52-week range $81.22–$158.28; today's close sits at 99% of that range, 0.6% below the 52-week high.
Oct 2, 2026 — RVTY rises 1.7% to $151.53
- Closed at $151.53, +1.66% vs the prior close of $149.06. Day range $148.55–$153.38, opened at $149.94.
- Volume was 1.24M shares, 0.7x its 50-day average of 1.89M.
- Price is +18.6% vs its 50-day average ($127.82) and +42.6% vs its 200-day average ($106.26).
- 52-week range $81.22–$158.28; today's close sits at 91% of that range, 4.3% below the 52-week high.
RVTY latest news & SEC filings
Every SEC filing by or about RVTY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gonzales Anita sold 84 shares at $155.48 (≈$13.06K) on Oct 1, 2026; now holds 7,117
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 23, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Krakowiak Maxwell sold 1,631 shares at $144.53 (≈$235.73K) on Sep 21, 2026; now holds 14,781
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vohra Tajinder S sold 7,330 shares at $140.88 (≈$1.03M) on Sep 16, 2026; now holds 6,635
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 5, 2026:
- Revenue: $729.69M (prior year $720.28M) (+1.3% vs Jun 29, 2025)
- Net income: $51.82M (prior year $53.95M) (-3.9% vs Jun 29, 2025)
- Diluted EPS: $0.47 (prior year $0.46) (+2.2% vs Jun 29, 2025)
Aug 4, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 20, 2026 · 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Jun 23, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade RVTY
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 2, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.45% (largest 6.0%).
- Liquidity: about 2.12M shares (≈$327.22M) trade per day on average.
- 52-week position: $154.71 vs a range of $81.22–$166.25 (86% of the range).
- Dividends: last ex-dividend date Jul 17, 2026 ($0.07/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 16 sales; latest: Maxwell Krakowiak sold 1,631 shares on Sep 21, 2026.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 4, 2026; 10-Q May 12, 2026.
- Share count: 111.59M shares outstanding (Aug 6, 2026), -3.9% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Laboratory Analytical Instruments.
RVTY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 151.91 | 156.86 | 148.83 | 154.71 | 2.37M |
| Oct 14, 2026 | 154.26 | 158.00 | 151.45 | 152.12 | 2.02M |
| Oct 13, 2026 | 156.44 | 157.46 | 153.10 | 155.08 | 1.39M |
| Oct 12, 2026 | 153.74 | 156.33 | 153.46 | 155.61 | 1.12M |
| Oct 9, 2026 | 152.40 | 155.50 | 152.40 | 154.18 | 1.22M |
| Oct 8, 2026 | 152.04 | 152.54 | 146.70 | 152.16 | 1.46M |
| Oct 7, 2026 | 153.03 | 156.01 | 149.25 | 153.60 | 2.23M |
| Oct 6, 2026 | 161.62 | 166.25 | 151.45 | 153.30 | 2.68M |
| Oct 5, 2026 | 151.45 | 157.45 | 150.39 | 157.36 | 1.55M |
| Oct 2, 2026 | 149.94 | 153.38 | 148.55 | 151.53 | 1.24M |
| Oct 1, 2026 | 155.48 | 155.48 | 148.31 | 149.06 | 2.48M |
| Sep 30, 2026 | 153.49 | 158.28 | 152.81 | 152.89 | 4.46M |
| Sep 29, 2026 | 150.49 | 153.06 | 149.29 | 152.77 | 1.60M |
| Sep 28, 2026 | 148.97 | 151.05 | 148.12 | 151.02 | 1.50M |
| Sep 25, 2026 | 150.70 | 151.99 | 147.03 | 151.11 | 1.94M |
| Sep 24, 2026 | 141.79 | 152.26 | 141.79 | 150.68 | 2.54M |
| Sep 23, 2026 | 142.40 | 145.00 | 140.08 | 142.11 | 2.24M |
| Sep 22, 2026 | 143.12 | 144.77 | 141.71 | 143.31 | 2.87M |
| Sep 21, 2026 | 144.53 | 145.55 | 142.30 | 143.59 | 2.06M |
| Sep 18, 2026 | 146.50 | 146.89 | 142.45 | 143.45 | 3.32M |
About Revvity
Revvity (RVTY) is listed on the NYSE and classified by the SEC under “Laboratory Analytical Instruments”. Its business address is in WALTHAM, MA. State of incorporation: MA. Fiscal year ends December 29. SEC CIK 31791.
RVTY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter Barrett | Director | May 11, 2026 |
| Samuel R. Chapin | Director | May 11, 2026 |
| Michael A Klobuchar | Director | May 11, 2026 |
| Alexis P Michas | Director | Aug 25, 2026 |
| Michelle Mcmurry-Heath | Director | May 11, 2026 |
| Prahlad R. Singh | Please See Remarks | Aug 17, 2026 |
| Sophie V. Vandebroek | Director | May 11, 2026 |
| Michel Vounatsos | Director | May 11, 2026 |
| Frank Witney | Director | May 11, 2026 |
| Pascale Witz | Director | May 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joel S Goldberg | Please See Remarks | Aug 18, 2026 |
| Anita Gonzales | Vice President and CAO | Jul 22, 2026 |
| Maxwell Krakowiak | Please See Remarks | Sep 23, 2026 |
| Prahlad R. Singh | Please See Remarks | Aug 17, 2026 |
| Miriame Victor | Please See Remarks | Feb 26, 2026 |
| Tajinder S Vohra | Please See Remarks | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 21, 2026 | Maxwell Krakowiak | Sale | 1,631 | $144.53 |
| Sep 16, 2026 | Tajinder S Vohra | Sale | 7,330 | $140.88 |
| Jul 20, 2026 | Anita Gonzales | Sale | 85 | $109.48 |
| Apr 20, 2026 | Anita Gonzales | Sale | 80 | $92.80 |
| Feb 24, 2026 | Miriame Victor | Sale | 1,862 | $97.13 |
| Feb 23, 2026 | Michelle Mcmurry-Heath | Sale | 600 | $97.26 |
| Feb 5, 2026 | Prahlad R. Singh | Sale | 7,885 | $100.63 |
| Feb 5, 2026 | Prahlad R. Singh | Sale | 12,186 | $99.55 |
| Feb 5, 2026 | Prahlad R. Singh | Sale | 1,307 | $99.02 |
| Feb 5, 2026 | Prahlad R. Singh | Sale | 1,068 | $102.52 |
| Feb 5, 2026 | Prahlad R. Singh | Sale | 3,079 | $101.45 |
| Feb 5, 2026 | Joel S Goldberg | Sale | 3,544 | $100.50 |
| Feb 5, 2026 | Joel S Goldberg | Sale | 532 | $102.52 |
| Feb 5, 2026 | Joel S Goldberg | Sale | 2,217 | $101.33 |
| Feb 5, 2026 | Joel S Goldberg | Sale | 6,424 | $99.47 |
RVTY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 28, 2025 | $2.86B | $241.20M | 2.07 | $582.93M |
| Dec 29, 2024 | $2.76B | $270.38M | 2.20 | $628.30M |
| Dec 31, 2023 | $2.75B | $693.09M | 5.55 | $91.27M |
| Jan 1, 2023 | $3.31B | $569.18M | 4.50 | $679.81M |
| Jan 2, 2022 | $3.83B | $943.16M | 8.08 | $1.41B |
Latest balance sheet: total assets $12.05B, total liabilities $4.82B, cash $1.02B (as of Jul 5, 2026).
RVTY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $111.39 |
| May 5, 2026 | 8-K Item 2.02 (results) | $92.30 |
| Feb 2, 2026 | 8-K Item 2.02 (results) | $107.09 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $110.14 |
| Oct 27, 2025 | 8-K Item 2.02 (results) | $97.16 |
| Jul 28, 2025 | 8-K Item 2.02 (results) | $95.04 |
| Apr 28, 2025 | 8-K Item 2.02 (results) | $95.06 |
| Jan 31, 2025 | 8-K Item 2.02 (results) | $126.13 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $122.70 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $124.82 |
| Jul 29, 2024 | 8-K Item 2.02 (results) | — |
| Apr 29, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Laboratory Analytical Instruments
Illumina (ILMN)Waters (WAT)Mettler Toledo International Inc/ (MTD)Agilent Technologies (A)10x Genomics (TXG)Bruker (BRKR)Avantor (AVTR)Bio-Rad Laboratories (BIO)Alamar Biosciences (ALMR)Pacific Biosciences Of California (PACB)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on RVTY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.